These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


367 related items for PubMed ID: 30374732

  • 1. MiRNA-99a can regulate proliferation and apoptosis of human granulosa cells via targeting IGF-1R in polycystic ovary syndrome.
    Geng Y, Sui C, Xun Y, Lai Q, Jin L.
    J Assist Reprod Genet; 2019 Feb; 36(2):211-221. PubMed ID: 30374732
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-145 Negatively Regulates Cell Proliferation Through Targeting IRS1 in Isolated Ovarian Granulosa Cells From Patients With Polycystic Ovary Syndrome.
    Cai G, Ma X, Chen B, Huang Y, Liu S, Yang H, Zou W.
    Reprod Sci; 2017 Jun; 24(6):902-910. PubMed ID: 27799458
    [Abstract] [Full Text] [Related]

  • 3. LncRNA HCP5 promotes cell proliferation and inhibits apoptosis via miR-27a-3p/IGF-1 axis in human granulosa-like tumor cell line KGN.
    Chen Y, Zhang X, An Y, Liu B, Lu M.
    Mol Cell Endocrinol; 2020 Mar 01; 503():110697. PubMed ID: 31891769
    [Abstract] [Full Text] [Related]

  • 4. The role of MiR-324-3p in polycystic ovary syndrome (PCOS) via targeting WNT2B.
    Jiang YC, Ma JX.
    Eur Rev Med Pharmacol Sci; 2018 Jun 01; 22(11):3286-3293. PubMed ID: 29917177
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-646 inhibits the proliferation of ovarian granulosa cells via insulin-like growth factor 1 (IGF-1) in polycystic ovarian syndrome (PCOS).
    Lu J, Xuan F, Chen A, Jin R, Zhou W, Ye Y, Ren Y.
    Endokrynol Pol; 2023 Jun 01; 74(3):305-314. PubMed ID: 37155307
    [Abstract] [Full Text] [Related]

  • 6. miR-323-3p regulates the steroidogenesis and cell apoptosis in polycystic ovary syndrome (PCOS) by targeting IGF-1.
    Wang T, Liu Y, Lv M, Xing Q, Zhang Z, He X, Xu Y, Wei Z, Cao Y.
    Gene; 2019 Jan 30; 683():87-100. PubMed ID: 30300681
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-9 affects isolated ovarian granulosa cells proliferation and apoptosis via targeting vitamin D receptor.
    Kong F, Du C, Wang Y.
    Mol Cell Endocrinol; 2019 Apr 15; 486():18-24. PubMed ID: 30794820
    [Abstract] [Full Text] [Related]

  • 8. Insulin attenuates the insulin-like growth factor-I (IGF-I)-Akt pathway, not IGF-I-extracellularly regulated kinase pathway, in luteinized granulosa cells with an increase in PTEN.
    Iwase A, Goto M, Harata T, Takigawa S, Nakahara T, Suzuki K, Manabe S, Kikkawa F.
    J Clin Endocrinol Metab; 2009 Jun 15; 94(6):2184-91. PubMed ID: 19318457
    [Abstract] [Full Text] [Related]

  • 9. Abnormality of Klotho Signaling Is Involved in Polycystic Ovary Syndrome.
    Mao Z, Fan L, Yu Q, Luo S, Wu X, Tang J, Kang G, Tang L.
    Reprod Sci; 2018 Mar 15; 25(3):372-383. PubMed ID: 28673204
    [Abstract] [Full Text] [Related]

  • 10. Follicular fluid derived exosomal miR-4449 regulates cell proliferation and oxidative stress by targeting KEAP1 in human granulosa cell lines KGN and COV434.
    Wang M, Sun Y, Yuan D, Yue S, Yang Z.
    Exp Cell Res; 2023 Sep 15; 430(2):113735. PubMed ID: 37517590
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of microRNA-19b promotes ovarian granulosa cell proliferation by targeting IGF-1 in polycystic ovary syndrome.
    Zhong Z, Li F, Li Y, Qin S, Wen C, Fu Y, Xiao Q.
    Mol Med Rep; 2018 Apr 15; 17(4):4889-4898. PubMed ID: 29363717
    [Abstract] [Full Text] [Related]

  • 12. Dysregulated miR-142, -33b and -423 in granulosa cells target TGFBR1 and SMAD7: a possible role in polycystic ovary syndrome.
    Li Y, Xiang Y, Song Y, Wan L, Yu G, Tan L.
    Mol Hum Reprod; 2019 Oct 28; 25(10):638-646. PubMed ID: 30865275
    [Abstract] [Full Text] [Related]

  • 13. Downregulating lncRNA NEAT1 induces proliferation and represses apoptosis of ovarian granulosa cells in polycystic ovary syndrome via microRNA-381/IGF1 axis.
    Zhen J, Li J, Li X, Wang X, Xiao Y, Sun Z, Yu Q.
    J Biomed Sci; 2021 Jul 15; 28(1):53. PubMed ID: 34266430
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome.
    Jiang L, Huang J, Li L, Chen Y, Chen X, Zhao X, Yang D.
    J Clin Endocrinol Metab; 2015 May 15; 100(5):E729-38. PubMed ID: 25695884
    [Abstract] [Full Text] [Related]

  • 15. Down-regulated lncRNA HOTAIR alleviates polycystic ovaries syndrome in rats by reducing expression of insulin-like growth factor 1 via microRNA-130a.
    Jiang B, Xue M, Xu D, Song J, Zhu S.
    J Cell Mol Med; 2020 Jan 15; 24(1):451-464. PubMed ID: 31733099
    [Abstract] [Full Text] [Related]

  • 16. Functional Characterization of MicroRNA-27a-3p Expression in Human Polycystic Ovary Syndrome.
    Wang M, Sun J, Xu B, Chrusciel M, Gao J, Bazert M, Stelmaszewska J, Xu Y, Zhang H, Pawelczyk L, Sun F, Tsang SY, Rahman N, Wolczynski S, Li X.
    Endocrinology; 2018 Jan 01; 159(1):297-309. PubMed ID: 29029022
    [Abstract] [Full Text] [Related]

  • 17. miR-3188 Regulates proliferation and apoptosis of granulosa cells by targeting KCNA5 in the polycystic ovary syndrome.
    Zhou S, Xia L, Chen Y, Guo W, Hu J.
    Acta Biochim Pol; 2021 Feb 03; 68(1):83-89. PubMed ID: 33533580
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of lncRNA ZFAS1 and upregulation of microRNA-129 repress endocrine disturbance, increase proliferation and inhibit apoptosis of ovarian granulosa cells in polycystic ovarian syndrome by downregulating HMGB1.
    Zhu HL, Chen YQ, Zhang ZF.
    Genomics; 2020 Sep 03; 112(5):3597-3608. PubMed ID: 32320818
    [Abstract] [Full Text] [Related]

  • 19. microRNA-194 is increased in polycystic ovary syndrome granulosa cell and induce KGN cells apoptosis by direct targeting heparin-binding EGF-like growth factor.
    Wu YX, Lin YS, Li SC, Yao X, Cheng M, Zhu L, Liu HY.
    Reprod Biol Endocrinol; 2021 Nov 23; 19(1):170. PubMed ID: 34814928
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.